ClinicalTrials.Veeva

Menu

HLA Antibodies in Systemic Lupus Erythematosus (LEDHLA)

C

Centre Hospitalier Universitaire, Amiens

Status

Enrolling

Conditions

HLA Antibodies
Systemic Lupus Erythematosus

Study type

Observational

Funder types

Other

Identifiers

NCT06921239
PI2025_843_0043

Details and patient eligibility

About

Patients suffering from autoimmune diseases show false-positive results when anti-HLA antibodies are identified. This false positivity makes it difficult to obtain an organ transplant based on immunological compatibility (absence of anti-HLA antibodies directed against graft antigens). The objectives of this project are to study the prevalence of these false positivities in a population of lupus patients, and to evaluate biological tests that can negate these false positivities.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients Adults
  • Followed in the internal medicine department of Amiens University Hospital - With systemic lupus erythematosus
  • Without HLA immunization risk factors (no history of pregnancy, transfusions or transplants)
  • With sera stored in the biobank

Exclusion criteria

  • minor Patients
  • Opposing the re-use of their personal data for research purposes

Trial contacts and locations

1

Loading...

Central trial contact

Nicolas GUILLAUME, Pr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems